Micro GLP-1: What Microdosing Really Means in the UK (October 2026)

01 · The core answer

Is micro GLP-1 right for you, or is there a safer way to start gently?

For almost everyone, the answer is no: there is a licensed way to start gently, and it does not involve altering the pen. It is not licensed, not supported by the pen's design and not endorsed by any UK regulator.¹ What people usually want is one of three things: lower cost, fewer side effects, or a slower pace. Each of those has a proper route.

Everyone starts Mounjaro on 2.5mg once a week, and many people settle at a maintenance dose of 5mg, 10mg or 15mg.¹ Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. You can see current options on the Mounjaro pen page, where all six doses are in stock.

Which option fits which worry

The table shows the pattern: every genuine concern behind micro GLP-1 already has a licensed answer. The difference is that the licensed answer comes with a prescriber who can monitor you, adjust your plan and record what happened.

The decision most readers actually face

Ask yourself whether you are really looking for a smaller dose, or for a slower, better-supported start. If it is the second, the licensed ladder does that. The starting dose is about letting your body adjust, not about weight loss itself, and a step to the next strength comes only after at least four weeks, depending on how you respond and tolerate it.¹ If side effects are bothering you, tell the prescriber rather than changing the pen yourself. Holding a dose longer or stepping down are options that sit within the licence.¹

If you are unsure whether treatment is suitable at all, start with the free online consultation, which is reviewed by a GPhC-registered prescriber. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Our weight loss clinic page explains the pathway, and our existing guide to micro dosing Mounjaro in the UK goes deeper on the tirzepatide version of this question.

One further point on honesty: weight loss with Mounjaro is gradual by design. Trials measured results at 72 weeks, so think in months, not days.¹ A trend that feels slow on the licensed ladder will not become faster on a smaller dose; it will simply be less predictable.

Related guides: Agonisti glp 1 and Ozempil glp-1.

Related guide: Wat is glp-1.

02 · What micro GLP-1 means

What micro GLP-1 means and why it is trending

Micro GLP-1 is a loose social media label for taking a fraction of the standard or starting dose of a GLP-1 medicine, usually semaglutide or tirzepatide. People also write it as micro-dosing GLP-1, GLP-1 micro or micro-dosing tirzepatide. There is no agreed definition, no standard schedule and no regulator behind it. Different online accounts describe different fractions and different gaps between doses, which is itself a warning sign: a treatment that nobody can define cannot be studied or checked.

The trend has two main motivations. The first is cost: a smaller dose looks as if it should make a pen last longer. The second is tolerability: people worry about nausea or a loss of appetite that feels too strong, and hope a smaller dose will soften it. Both are understandable. Neither is a good reason to alter a medicine whose dosing was designed and tested at specific strengths.

It is also promoted heavily by wellness businesses and telehealth platforms that benefit from selling a lower-cost-looking product. When a seller offers dramatic weight-loss claims with a tiny dose, treat the claim as marketing rather than medicine. No approved clinical trial supports micro dosing for meaningful long-term weight loss or metabolic health, so any promised result has nothing behind it.

It helps to be clear about the vocabulary. Micro GLP-1 is not a drug class, a product or a clinical term. A GLP-1 medicine is a prescription treatment with a licensed dose range.

For Mounjaro specifically, the licensed medicine is tirzepatide, a once-weekly injection made by Eli Lilly and licensed in the UK for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen, called a KwikPen, in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ That is the entire set of strengths designed, tested and approved. Anything described as smaller than 2.5mg is outside the licence, and anything made by splitting a pen is not what the pen was built to do.

It is worth separating the worry from the workaround. If you are anxious about starting, the licensed starting dose is already the gentle option. If you are worried about price, talk to your clinical team rather than stretching a product past its design. If you are worried about side effects, report them and let a clinician adjust within the licence.

The short summary for readers who want to move on: micro GLP-1 is popular because it sounds careful, but a careful approach is exactly what the licensed ladder, monthly reviews and prescriber oversight already provide.

03 · Pen design and dosing

Why the pen design does not allow micro doses

The Mounjaro KwikPen is built to deliver set weekly doses, not fractions. You set the dose by turning the dose knob until the dose indicator shows the correct dose in the window. That single instruction removes most of the mechanical routes people imagine for micro dosing, because a click-counting approach is explicitly not how the pen should be read.

Altering doses outside the licence means unknown dosing accuracy and no safety data.¹ Those last two phrases matter. Unknown dosing accuracy means neither you nor a clinician can tell how much medicine you actually received. No safety data means nobody has studied what happens when it is done this way.

Injection basics still apply

The licensed method is simple. Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food. Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose.¹ There is no best time of day: Mounjaro works the same morning or evening. What matters is the same day each week, and many people choose a weekend morning so early side effects fall on days off.

Spreading doses out is the second half of the micro dosing idea, and it runs into the same wall. The schedule is weekly. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day, never taking two doses within 3 days of each other.¹

You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹ That flexibility is the licensed way to fit treatment around your life. It is not a mechanism for spacing doses further apart or for deliberately reducing exposure.

If you ever notice that a pen feels wrong, that the dose will not dial, or that you are unsure what you injected, do not improvise. Contact the pharmacy or your prescriber. Our existing week by week micro dosing guide sets out how the licensed titration compares with the micro dosing talk week by week.

04 · Licensed gentle options

The licensed ways to go slower

If you want a gentler pace, the licence already offers it. Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹ After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.¹ A lower maintenance dose that you tolerate well and keep taking is a sound outcome.

Holding or stepping down

When you order with us, ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team are part of the service, with side-effect support available. Repeat orders re-check suitability, and there is no auto-shipping.

What the first weeks should feel like

The 2.5mg starting weeks are about adjustment, and experiences differ widely. Some people notice appetite change and early loss in week one, while others feel little until a higher dose. Both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

Knowing that matters because many people turn to micro dosing after an unpleasant first week and assume the medicine is too strong. Often the better response is patience and a conversation with the prescriber. Tell them what happened, when it happened relative to the injection and how long it lasted.

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.¹

Finally, remember that a different plan is possible at any point. If tirzepatide is not suiting you, a prescriber can discuss other licensed approaches, including those described on our Wegovy pen page, rather than you inventing a lower dose of your current medicine. The common thread is that decisions are made with a clinician, using known strengths, and recorded so the next review has accurate information.

05 · Evidence gap

What the evidence shows, and what it does not

The evidence for GLP-1 and GIP medicines comes from trials of full licensed doses, not micro doses. The best-known tirzepatide result is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Notice what that trial tested: specific strengths, given on the licensed schedule, over a long period. It did not test fractions of a pen, irregular gaps or homemade dilutions. That means none of those percentages can be borrowed to justify micro GLP-1. Doing so would be like quoting the result of one exercise programme to defend a different one that nobody has measured.

For readers who like a worked example: for someone starting at 100 kg, 20.9% is about 21 kg. That example describes the trial average on the top dose, not a prediction for you and not a promise for any lower dose. Trial averages do not predict your own result.

No robust data for sub-therapeutic dosing

There are individual accounts, but individual accounts are not evidence of effect, and they are rarely accompanied by information about the actual dose received. When someone reports success on a micro dose, you cannot tell whether the dose, the diet change, the water weight or simple chance explains it.

The honest summary is therefore a gap, not a verdict.

Realistic pace and review

On the licensed ladder, progress is reviewed. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That checkpoint is meaningful because the dose is known. With micro dosing there is no equivalent: if progress is slow, you cannot tell whether the medicine failed or the dosing did.

The same trial sentence is also a useful reminder that treatment is a package. A reduced-calorie diet and more physical activity are part of the licensed use. If a seller describes a micro dose as a way to lose weight without changing anything, the claim is not backed by the trial that built the medicine's reputation.

06 · Sourcing and compounding risks

Compounded, split and unregulated supply

Micro GLP-1 offers are often tied to compounded or relabelled products, and that is where the highest risk sits. Compounded versions are made outside the process that produces a licensed pen, and the strength, purity and sterility of what you receive are harder to verify. The risks include contamination, dosing errors and unclear labelling. A tiny dose from an unverified vial is not safer than a known dose from a licensed pen; it is simply less visible.

The MHRA publishes guidance and counterfeit medicine alerts, and runs the Yellow Card scheme for reporting side effects and suspect products.⁷ If you have already taken something unusual, or you suspect a product is not what it claims to be, you can report it through the Yellow Card scheme.¹⁹

Red flags to walk away from

• A seller offering to supply without a consultation or prescription.
• Dramatic weight-loss claims, or any promise of specific results.
• Products described as micro or mini versions of a prescription medicine without a licensed strength.
• Pens or vials with unclear labelling, no pharmacy name or no way to contact a pharmacist.
• Requests to pay through unusual channels or pressure to buy immediately.

Prescription-only medicines should come from a registered pharmacy after a clinical review. You can check any pharmacy on the GPhC public register, and ours is registered under GPhC 9012878.¹² We supply Mounjaro through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens, with all six doses stocked from 2.5mg to 15mg.

Why a smaller amount does not remove the risk

People sometimes assume that a tiny dose lowers every risk. It lowers the chance of strong side effects only if the dose is what you think it is. When doses are measured from a shared vial, drawn by hand or divided by guesswork, the actual amount can be far from the intended one in either direction.

There is also a practical risk of delay. Someone who relies on a micro dose may postpone seeing a clinician, miss real problems and later find that they have spent months without a proper plan. A consultation with a GPhC-registered prescriber costs nothing with us, carries no obligation, and gives you a record of what was agreed.

If you have questions about what you have already bought or taken, our team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413. We would rather answer a question early than see someone continue with a product we cannot vouch for.

07 · Mechanism and clearance

How GLP-1 medicines work, and why dose matters

GLP-1 is a natural gut hormone, and GLP-1 medicines copy part of its action. That answers a common question: GLP-1 is not the same thing as Mounjaro, but Mounjaro acts on GLP-1 receptors. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹

Why a long half-life changes the micro dosing logic

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Changing amounts or gaps at random makes your levels less predictable, not more.

The licensed schedule takes this into account. A micro dosing plan invented from a social media post cannot make use of that reasoning because it does not know your starting point.

Stomach emptying and other medicines

Slowed stomach emptying is part of how these medicines work, and it is also why they can reduce absorption of oral contraceptives. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If this applies to you, tell the prescriber during your consultation. Likewise, if you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar, which is another reason to have a clinician involved rather than self-adjusting.⁷

The patient information leaflet lists the side effects and warnings in detail and is the right place to check anything specific to your health.¹³ If a new symptom appears that you cannot explain, speak to your prescriber and consider reporting it through Yellow Card. None of this is easier to do when you cannot say what dose you took.

08 · Natural options and other medicines

Mimicking GLP-1 naturally, pills and other routes

Nothing sold as a natural GLP-1 booster is a substitute for prescribed treatment. Products marketed as nature's Ozempic or similar are low-cost supplements with no clinical oversight, and their dosing is not standardised. If you want to help your body regulate appetite, the proven foundation is the one the licence itself relies on: a reduced-calorie diet and increased physical activity.¹ A GP or pharmacist can help with the practical side.

Do the GLP-1 pills work?

Oral GLP-1 options exist and have their own product information. Wegovy tablets contain oral semaglutide, and Foundayo is a separate once-daily tablet medicine, each with its own prescribing information.²⁰²¹ Their trial programmes are separate from Mounjaro's, so their results should not be set side by side with tirzepatide as if they were head to head.

Injections other than Mounjaro

Wegovy (semaglutide) is a once-weekly pen with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg. Titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17, and 2.4mg is the licensed maintenance dose for weight management.¹⁸ Liraglutide, supplied at 6mg/ml, is a daily injection, unlike once-weekly Mounjaro and Wegovy.

NHS or private?

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults who meet specific criteria, and the primary-care rollout began in June 2025 with the highest-need groups first.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. Ask your GP about your own eligibility.

Can you get a GLP-1 medicine if you are not overweight?

Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes, and a prescriber will assess your BMI, medical history and current medicines before deciding whether it is suitable for you. If you are concerned about your weight or health but are not sure you qualify, a free consultation is a safe way to find out.

What is the fastest legitimate way to start?

The fastest regulated route is a short online consultation with a prescriber review. If approved, same-day dispatch applies when you order by 3pm, followed by free next-day tracked delivery in temperature-controlled packaging. There is also a free companion app, GLPTrackr, for tracking your journey on iOS and Android. Speed matters less than safety, but a legitimate route is rarely slower than a risky one.

09 · Using your pen safely

Storage, travel and everyday safe use

If you start the licensed route, correct handling protects the dose you paid for. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, which is useful for short trips, after which it should be discarded. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

You can fly with Mounjaro. Carry pens in hand luggage, because hold luggage can fall below freezing, ideally in a cool bag with the prescription label or a copy of your prescription. In-use pens tolerate up to 30 days not above 30°C, so most holidays need no special arrangements. For hot climates use an insulated pouch, and check destination rules for travelling with prescription injectables before you fly.¹

Unopened pens should be kept in the fridge and keep until the expiry date printed on the box. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit, since figures circulating online often come from other countries' labels.¹ This is a good example of why unverified advice is a problem: a number that sounds precise may be for a different product in a different market.

Habits that make the licensed route work

• Pick one injection day and a time you will remember, and keep to it.
• Rotate the injection site each week.
• Keep a simple log of dose, day and any symptoms, or use the GLPTrackr app.
• Tell the prescriber about side effects early rather than adjusting the pen.

Needles, a sharps bin and injection guidance are included with every order, so you are not left working out the basics alone. If something does not look right with your pen on arrival, contact us within 3 days, as faulty, damaged or wrong items are the exception to our no-returns rule for dispensed prescription medicines.

When to speak to someone

Contact your prescriber if side effects persist, if you are unsure about a missed dose, or if you are thinking about changing your regimen for any reason. A conversation costs nothing and can often solve the worry that led you to micro dosing in the first place. If you suspect a side effect or a faulty product, you can also report it via Yellow Card.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹